French study tracks Real-World safety of automated insulin system
Disease control
Not yet recruiting
This study will monitor the safety and performance of an automated insulin delivery system (Control-IQ) in 350 people with type 1 diabetes in France. It aims to see how well the system controls blood sugar and improves quality of life during everyday use over 12 months. The study…
Sponsor: Tandem Diabetes Care, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC